Sigma-Genosys Overview

  • Founded
  • 1987
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 7

Sigma-Genosys General Information

Description

Developer of synthetic DNA and peptides. The company is engaged in the development and supply of oligonucleotides, gene arrays, synthetic peptides, genes and research reagents for life science research at pharmaceutical and biotechnology companies, universities and clinical laboratories.

Contact Information

Formerly Known As
Genosys Biotechnologies, Genetic Design
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Primary Office
  • 1442 Lake Front Circle
  • Suite 185
  • The Woodlands, TX 77380
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sigma-Genosys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sigma-Genosys‘s full profile, request access.

Request a free trial

Sigma-Genosys Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sigma-Genosys‘s full profile, request access.

Request a free trial